Answers are grounded in this paper and cite their sources.
Case report demonstrates successful four-year etanercept treatment in coexisting familial Mediterranean fever and juvenile idiopathic arthritis, highlighting targeted biologics for complex disease.
Familial Mediterranean fever (FMF) is an autoinflammatory disorder characterized by recurrent febrile polyserositis and arthritis attacks. Accompanying seronegative spondyloarthropathy has been reported in FMF in addition to its own joint involvement. However, the coexistence of FMF with juvenile idiopathic arthritis (JIA) is very rare, only three cases with severe joint involvement and mortal outcome have been reported in the literature. Here, we present another case with FMF and JIA with osteoporosis, successfully treated with etanercept with a four-year follow-up.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: